Paclitaxel loaded hyaluronic acid nanoparticles for targeted cancer therapy: In vitro and in vivo analysis

International Journal of Biological Macromolecules

Volumn 72, Issue , 2014, Pages 510-518

  Thomas, Reju G ^a   Moon, MyeongJu ^b   Lee, SeJy ^a   Jeong, Yong Yeon ^a  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b DKC Corporation (BioActs)   (South Korea)

Author keywords

Cancer; Hyaluronic acid; Nanoparticle

Indexed keywords

FLUORESCENT DYE; HERMES ANTIGEN; HYALURONATE CHOLANIC ACID NANOPARTICLE; HYALURONIC ACID DERIVATIVE; NANOPARTICLE; PACLITAXEL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; HYALURONIC ACID; MICELLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BIODEGRADABILITY; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CHEMICAL LABELING; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG TARGETING; EMBRYO; FLUORESCENCE IMAGING; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOLECULARLY TARGETED THERAPY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; ZETA POTENTIAL; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; MICE; MICELLES; MOLECULAR TARGETED THERAPY; NANOPARTICLES; NEOPLASMS; PACLITAXEL;

EID: 84907819885     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.08.054     Document Type: Article

References (35)

1. Surapaneni M.S., Das S.K., Das N.G. ISRN Pharmacol. 2012, 62:31-39.
2. Kumar S., Mahdi H., Bryant C., et al. Int. J. Womens Health 2010, 2:411-427.
3. Zhou R., Mazurchuk R.V., Tamburlin J.H., et al. J. Pharmacol. Exp. Ther. 2010, 332:479-488.
4. Heneweer C., Holland J.P., Divilov V., et al. J. Nucl. Med. 2011, 52:625-633.
5. Dubey N., Shukla J., Hazari P.P., et al. Hell. J. Nucl. Med. 2012, 15:9-15.
6. Averineni R., Shavi G., Gurram A., et al. Bull. Mater. Sci. 2012, 35:319-326.
7. Siegel R., Naishadham D., Jemal A. CA Cancer. J. Clin. 2012, 62:10-29.
8. Kokko L.L., Hurme S., Maula S.M., et al. Oral. Oncol. 2011, 47:510-516.
9. Prince M.E., Sivanandan R., Kaczorowski A., et al. Proc. Natl. Acad. Sci. USA 2007, 104:973-978.
10. Toole B.P. Nat. Rev. Cancer 2004, 4:528-539.
11. Zhou B., Weigel J.A., Fauss L., et al. J. Biol. Chem. 2000, 275:37733-37741.
12. Jung H.S., Kong W.H., Sung D.K., et al. ACS Nano 2014, 8:260-268.
13. Choi K.Y., Min K.H., Na J.H., et al. J. Mater. Chem. 2009, 19:4102-4107.
14. Boeriu C.G., Springer J., Kooy F.K., et al. Int. J. Carbohydr. Chem. 2013, 2013:1-14.
15. Jing J., Alaimo D., De Vlieghere E., et al. J. Mater. Chem. B 2013, 1:3883-3887.
16. Liu Y., Sun J., Lian H., et al. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 935:10-15.
17. Wei X., Senanayake T.H., Warren G., et al. Bioconjug. Chem. 2013, 24:658-668.
18. Saravanakumar G., Deepagan V.G., Jayakumar R., et al. J. Biomed. Nanotechnol. 2014, 10:17-31.
19. Anisha B.S., Deepthi S., Jayakumar R., et al. Carbohydr. Polym. 2013, 92:1561-1565.
20. Park J.H., Cho H.J., Yoon H.Y., et al. J. Control. Release 2014, 174:98-108.
21. Ossipov D.A. Expert Opin. Drug Deliv. 2010, 7:681-703.
22. Deng L., Wang G.C., Ren J., et al. RSC Adv. 2012, 2:12909-12914.
23. Lee D-E., Kim A.Y., Yoon H.Y., et al. J. Mater. Chem. 2012, 22:10444-10447.
24. Mok H., Jeong H., Kim S.J., et al. Chem. Commun. (Camb.) 2012, 48:8628-8630.
25. Saravanakumar G., Choi K.Y., Yoon H.Y., et al. Int. J. Pharm. 2010, 394:154-161.
26. Orr G.A., Verdier-Pinard P., McDaid H., et al. Oncogene 2003, 22:7280-7295.
27. Liu Y., Sun J., Cao W., et al. Int. J. Pharm. 2011, 421:160-169.
28. Ayers G.D., McKinley E.T., Zhao P., et al. J. Ultrasound Med. 2010, 29:891-901.
29. Franzmann E.J., Schroeder G.L., Goodwin W.J., et al. Int. J. Cancer 2003, 106:438-445.
30. Li C., Price J.E., Milas L., et al. Clin. Cancer Res. 1999, 5:891-897.
31. Lee H., Mok H., Lee S. J. Control. Release 2007, 119:245-252.
32. Peer D., Margalit R. Neoplasia 2004, 6:343-353.
33. Ruoslahti E., Bhatia S.N., Sailor M.J. J. Cell Biol. 2010, 188:759-768.
34. Choi K.Y., Min K.H., Yoon H.Y., et al. Biomaterials 2011, 32:1880-1889.
35. Jokerst J.V., Lobovkina T., Zare R.N., et al. Nanomedicine (London, UK) 2011, 6:715-728.